Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)
暂无分享,去创建一个
H. Yokoyama | Y. Kurihara | H. Miyoshi | T. Atsumi | A. Nakamura | H. Nomoto | Kazuno Omori | Shinichiro Kawata | S. Aoki | K. Cho | N. Manda | Hajime Sugawara | S. Nagai | J. Takeuchi | Kazuhisa Tsuchida